Breaking News

Avion Pharma Appoints President

By Kristin Brooks | March 12, 2014

Sullivan to lead growth initiatives

Mike Sullivan has been named president of Avion Pharmaceuticals. Mr. Sullivan joined the company in 2011 as vice president of sales and marketing. He has expertise in building corporate "start-up" pharmaceutical organizations and has been instrumental in the commercial development, infrastructure and successful launch of Avion during the past three years. Mr. Sullivan has spearheaded eight product launches at Avion, while also re-launching the prescription Prenate Prenatal Vitamin Family. Mr. Sullivan has also held senior management positions with UCB Pharma, Novartis, Sanofi and Ther-Rx Pharmaceuticals.     

"I am pleased to announce Mike's promotion and applaud his inexhaustible dedication to drive continuous success for Avion Pharmaceuticals. Mike exhibits endless passion in realizing our strategic mission to be the leading pharmaceutical company in the U.S. devoted to women's healthcare. With Mike's leadership, Avion is positioned to continue our growth through innovation by providing women and babies with products and support needed to live healthy and rewarding lives," said Mark Pugh, chief executive officer for Avion Pharmaceuticals.

blog comments powered by Disqus
  • Cold Chain Packaging Trends

    Cold Chain Packaging Trends

    Kristin Brooks, Contract Pharma||February 4, 2016
    Susan Li of UPS discusses supply chain trends, challenges, and packaging innovations

  • Packaging Equipment Trends Preview

    Packaging Equipment Trends Preview

    Kristin Brooks, Contract Pharma||January 26, 2016
    Christian Treitel of Bosch Packaging Technology discusses trends and capabilities

  • Tackling Drug Serialization Challenges

    Tackling Drug Serialization Challenges

    Tim Wright, editor||January 22, 2016
    Siemens and Adents together will develop a combined hardware plus software solution for pharma industry

  • Elemental Impurity Testing

    Elemental Impurity Testing

    Dr. Andrew Fussell, PANalytical ||January 28, 2016
    Advances in elemental impurity testing aid compliance with new USP requirements

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.

  • Optimizing Collaboration Effectiveness in Alliance Partnerships

    Optimizing Collaboration Effectiveness in Alliance Partnerships

    Mary Jo Lamberti, Phil Birch, Ranjana Chakravarthy, Ken Getz, Tufts CSDD||January 28, 2016